{"id":"NCT01715415","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults","officialTitle":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered With Ribavirin (RBV) in Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (SAPPHIRE-II)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2013-11","completion":"2014-10","firstPosted":"2012-10-29","resultsPosted":"2015-01-06","lastUpdate":"2021-08-02"},"enrollment":395,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Infection"],"interventions":[{"type":"DRUG","name":"ABT-450/r/ABT-267, ABT-333","otherNames":["ABT-267 also known as ombitasvir","ABT-450 also known as paritaprevir","ABT-333 also known as dasabuvir","Viekira PAK"]},{"type":"DRUG","name":"Ribavirin","otherNames":[]},{"type":"DRUG","name":"Placebo for ABT-450/r/ABT-267","otherNames":[]},{"type":"DRUG","name":"Placebo for ABT-333","otherNames":[]},{"type":"DRUG","name":"Placebo for ribavirin","otherNames":[]}],"arms":[{"label":"ABT-450/r/ABT-267 and ABT-333, plus RBV","type":"EXPERIMENTAL"},{"label":"Placebo Followed by ABT-450/r/ABT-267 and ABT-333, plus RBV","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of ABT-450, ritonavir and ABT-267 (ABT-450/r/ABT-267; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) co-administered with ribavirin (RBV) in hepatitis C virus genotype 1 infected treatment-experienced adults.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment","timeFrame":"12 weeks after the last actual dose of active study drug","effectByArm":[{"arm":"ABT-450/r/ABT-267 and ABT-333, Plus RBV","deltaMin":96.3,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24720679","29377566"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":297},"commonTop":["HEADACHE","FATIGUE","NAUSEA","ASTHENIA","DYSPNOEA"]}}